Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,125 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies

NCT04919018

Conditions
Abnormalities, Multiple, Bronchial Diseases, Bronchiectasis, +20 more
Locations
  • Washington University in St. Louis St Louis, Missouri, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • The Hospital for Sick Children Toronto, Ontario, Canada
  • McGill University Montreal, Quebec, Canada
View Trial Details
Completed

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

NCT04702243

Conditions
Abnormalities, Multiple, Bronchial Diseases, Bronchiectasis, +20 more
Locations
  • Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • National Heart, Lung and Blood Institute Bethesda, Maryland, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Completed

PositiveLinks: mHealth for DC Cohort

NCT04998019

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • MetroHealth Washington D.C., District of Columbia, United States
  • Unity Medical Center Washington D.C., District of Columbia, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • La Clinica Del Pueblo Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details
Completed

Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany

NCT03754803

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Aachen, Germany
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site Berlin, Germany
View all 18 locations
View Trial Details
Completed

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

NCT01771107

Conditions
AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma, +23 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 28 locations
View Trial Details
Completed

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

NCT02602262

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • University of Colorado Denver Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details

Related conditions